Sauna Sessions Boost Vascular Function and Exercise Capacity in Kidney Disease Patients
A pilot trial finds a single far-infrared sauna session improves blood vessel function and walking capacity in CKD patients without harming kidneys.
Summary
Researchers at Virginia Commonwealth University tested whether passive heat exposure via far-infrared sauna could benefit patients with chronic kidney disease (CKD). In a randomized crossover study of 10 CKD patients, a single 25-minute sauna session at 60°C significantly improved both macrovascular function (flow-mediated dilation) and microvascular function (limb blood flow response) compared to a thermoneutral control condition. Exercise capacity, measured by the 6-minute walk test, also improved meaningfully. Critically, no adverse effects on kidney function or markers of acute kidney injury were detected in the 24 hours following heat exposure. These preliminary findings suggest heat therapy may be a safe and promising cardiovascular intervention for CKD patients.
Detailed Summary
Chronic kidney disease affects millions of people worldwide and dramatically elevates cardiovascular risk. Two key drivers of this risk — vascular dysfunction and exercise intolerance — currently lack effective, accessible therapeutic interventions. Passive heat exposure (such as sauna use) has shown promise in healthy populations and those with heart failure, but had never been studied in CKD patients, partly due to concerns about kidney stress.
This pilot randomized crossover trial enrolled 10 adults with Stage G2–G4 CKD (mean age 41 years, average eGFR 55 mL/min/1.73 m²). Participants completed two experimental visits: a 25-minute far-infrared sauna session at 60°C and a thermoneutral control session at 22°C, separated by a washout period. Vascular and exercise assessments were performed after a 60-minute recovery window following each session.
Results were striking for such a small pilot. Flow-mediated dilation — a gold-standard measure of macrovascular (large vessel) health — was nearly doubled after the sauna session (6.68%) compared to control (3.84%). Microvascular function, assessed via the blood flow response to passive leg movement, also improved significantly. Six-minute walk distance increased by approximately 38 yards after heat exposure, a clinically meaningful difference. Importantly, urinary markers of kidney function and acute kidney injury showed no significant changes over 24 hours post-sauna.
These findings are notable because they suggest a single heat session can acutely shift vascular physiology in a beneficial direction without burdening already-compromised kidneys. The mechanisms likely involve heat-induced vasodilation, nitric oxide release, and hemodynamic stress similar to moderate exercise.
Caveats are significant: this was a very small pilot with only 10 participants, acute effects do not confirm chronic benefit, and longer-term kidney safety with repeated sessions remains untested. Larger controlled trials are needed before clinical recommendations can be made.
Key Findings
- Flow-mediated dilation nearly doubled after sauna (6.68%) vs. thermoneutral control (3.84%), indicating improved macrovascular function.
- Microvascular blood flow response to passive limb movement was significantly greater after heat exposure (AUC 243 vs. 179 arbitrary units).
- Six-minute walk distance improved by ~38 yards after sauna, a clinically meaningful gain in exercise capacity.
- No significant adverse changes in kidney function or acute kidney injury biomarkers were detected up to 24 hours post-session.
- This is the first study to examine vascular and renal responses to passive heat exposure specifically in CKD patients.
Methodology
Randomized crossover pilot trial with 10 Stage G2–G4 CKD patients comparing a 25-minute far-infrared sauna (60°C) to a thermoneutral control (22°C). Vascular outcomes (FMD, passive limb movement blood flow) were assessed after 60 minutes of recovery; exercise capacity was measured via the 6-minute walk test; urinary kidney injury markers were collected immediately and at 24 hours post-exposure.
Study Limitations
The sample size of 10 participants is very small, limiting statistical power and generalizability. Only acute effects were measured — chronic kidney safety and sustained vascular benefits from repeated sessions remain unknown. The relatively young mean age (41 years) may not represent the broader, older CKD population.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: